Profitability
This table compares Zadar Ventures and Eisai’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Zadar Ventures | N/A | -52.43% | -45.38% |
| Eisai | 4.11% | 3.86% | 2.50% |
Institutional & Insider Ownership
0.0% of Eisai shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Risk & Volatility
Zadar Ventures has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Eisai has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zadar Ventures | N/A | N/A | -$240,000.00 | ($0.02) | N/A |
| Eisai | $6.74 billion | 2.62 | $426.79 million | $0.87 | 70.70 |
Eisai has higher revenue and earnings than Zadar Ventures. Zadar Ventures is trading at a lower price-to-earnings ratio than Eisai, indicating that it is currently the more affordable of the two stocks.
Summary
Eisai beats Zadar Ventures on 8 of the 9 factors compared between the two stocks.
About Zadar Ventures
Zadar Ventures Ltd. engages in the acquisition, exploration, and development of mineral resource properties in Canada. The company was incorporated in 2008 and is headquartered in Vancouver, Canada.
About Eisai
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Zadar Ventures Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zadar Ventures and related companies with MarketBeat.com's FREE daily email newsletter.
